@article{a3729eaac07b4704a28905cdd7b67fc2,
title = "Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting",
keywords = "Pdac, Syrian hamster, Adenovirus, Artificial intelligence, Immune checkpoint inhibitor, Immunotherapy, Molecular simulations, Oncolytic virus, 3121 General medicine, internal medicine and other clinical medicine",
author = "Clubb, {James H. A.} and Kudling, {Tatiana V.} and Mykhailo Girych and Lyna Haybout and Santeri Pakola and Firas Hamdan and Victor Cervera-Carrascon and Annabrita Hemmes and Susanna Gr{\"o}nberg-V{\"a}h{\"a}-Koskela and Santos, {Joao Manuel} and Quixabeira, {Dafne C. A.} and Saru Basnet and Camilla Heini{\"o} and Victor Arias and Elise Jirovec and Shreyas Kaptan and Riikka Havunen and Suvi Sorsa and Abdullah Erikat and Joel Schwartz and Marjukka Anttila and Katri Aro and Tapani Viitala and Ilpo Vattulainen and Vincenzo Cerullo and Anna Kanerva and Akseli Hemminki",
year = "2023",
month = feb,
day = "3",
doi = "10.3389/fimmu.2023.1060540",
language = "English",
volume = "14",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media",
}